These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6391883)

  • 1. Indomethacin sustained-release?
    Green JA
    Drug Intell Clin Pharm; 1984 Dec; 18(12):1004-7. PubMed ID: 6391883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sustained release on the pharmacokinetic profile of indomethacin in man.
    Yeh KC; Berger ET; Breault GO; Lei BW; McMahon FG
    Biopharm Drug Dispos; 1982; 3(3):219-30. PubMed ID: 7139063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of an osmotically controlled delivery indomethacin preparation in normal volunteers.
    Bertouch JV; Maycock S; Harrington B; Brooks PM
    Clin Exp Pharmacol Physiol; 1983; 10(4):411-4. PubMed ID: 6627754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative multiple dose kinetics of two formulations of indomethacin.
    Verbesselt R; Tjandramaga TB; Mullie A; De Schepper PJ; Cook T; Derouwaux C; Kramp R; Hwang S
    Eur J Clin Pharmacol; 1983; 24(4):563-8. PubMed ID: 6861873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of new indomethacin dosage forms.
    Waller ES
    Pharmacotherapy; 1983; 3(6):324-33. PubMed ID: 6361702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerance of slow-release indomethacin tablets in rheumatoid arthritis.
    Kaarela K; Lehtinen K; Mäkisara P; Holttinen K; Lamminsivu U; Gordin A
    Eur J Clin Pharmacol; 1982 Oct; 23(4):349-51. PubMed ID: 7173304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic overview of indomethacin and sustained-release indomethacin.
    Yeh KC
    Am J Med; 1985 Oct; 79(4C):3-12. PubMed ID: 3904441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of sustained-release preparation of indomethacin].
    Sasaki S
    Ryumachi; 1972 Nov; 12(3):253-70. PubMed ID: 4576240
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of a sustained-release product of indomethacin in the elderly.
    Bruguerolle B; Barbeau G; Bélanger PM; Labrecque G
    Gerontology; 1986; 32(5):277-85. PubMed ID: 3569930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indomethacin kinetics and urinary excretion of prostaglandin E2 following oral administration of various dosage forms of indomethacin].
    Düsing R; Dittrich P; Kukovetz WR; Lehmann K; Kramer HJ
    Z Rheumatol; 1983; 42(4):235-41. PubMed ID: 6580789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of indomethacin from two multiple-units controlled-release formulations.
    Bechgaard H; Brodie RR; Chasseaud LF; Houmøller P; Hunter JO; Siklos P; Taylor T
    Eur J Clin Pharmacol; 1982; 21(6):511-5. PubMed ID: 7075656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicentre double-blind comparison of sustained action formulations of tiaprofenic acid and indomethacin in osteoarthritis.
    Calin A; Cawley MI; Pal B; Rosenberg JN; Silas AM; Williams PI
    Drugs; 1988; 35 Suppl 1():57-63. PubMed ID: 3282867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release indomethacin (Indotard). Clinical trial in patients with rheumatoid arthritis.
    Ejstrup L; Freisleben Sørensen S; Hellesen C; Jurik AG; Mune O; Skinhøj A
    Scand J Rheumatol; 1984; 13(2):147-50. PubMed ID: 6377492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of different indomethacin formulations in young and elderly patients: a comparative controlled clinical trial.
    Kaarela K; Lehtinen K; Skinhøj A; Andersen F
    Curr Med Res Opin; 1989; 11(7):427-31. PubMed ID: 2673662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of indomethacin from a modified release system containing indomethacin as the lysine salt.
    Marzo A; Reiner A; Arrigoni Martelli E; Conte U; Colombo P; La Manna A
    Eur J Clin Pharmacol; 1987; 32(1):85-7. PubMed ID: 3108010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronopharmacokinetic study of a prolonged release form of indomethacin.
    Guissou P; Cuisinaud G; Llorca G; Lejeune E; Sassard J
    Eur J Clin Pharmacol; 1983; 24(5):667-70. PubMed ID: 6873148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.
    Adams KR; Halliday LD; Sibeon RG; Baber N; Littler T; Orme ML
    Br J Clin Pharmacol; 1982 Aug; 14(2):286-9. PubMed ID: 7104182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the in vitro dissolution behaviour of various indomethacin formulations with their in vivo bioavailability.
    Rowe JS; Carless JE
    J Pharm Pharmacol; 1981 Sep; 33(9):561-4. PubMed ID: 6117632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of drug delivery.
    Robinson DS
    Curr Med Res Opin; 1983; 8 Suppl 2():10-9. PubMed ID: 6851621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and efficacy of a slow-release indomethacin tablet in ankylosing spondylitis.
    Lehtinen K; Kaarela K; Mäkisara P; Holttinen K; Gordin A
    Br J Rheumatol; 1984 Feb; 23(1):52-6. PubMed ID: 6365231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.